Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00445A100 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Trium Capital LLP 13D/A Amendment 2 | 0% |
5/27/2025
Event 5/23/2025
|
|
|
Tang Capital Management LLC
13D/A
Amendment 3
|
0% |
5/23/2025
Event 5/21/2025
|
|
| Tang Capital Management, LLC | 0% | ||
| Kevin Tang | 0% | ||
| Tang Capital Partners, LP | 0% | ||
| Tang Capital Partners International, LP | 0% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
| Concentra Biosciences, LLC | 0% | ||
|
Access Industries Management, LLC
13D/A
Amendment 2
|
0% |
5/23/2025
Event 5/21/2025
|
|
| Access Industries Management, LLC | 0% | ||
| Access Industries Holdings LLC | 0% | ||
| AI Acel LLC | 0% | ||
| Len Blavatnik | 0% | ||
|
AyurMaya Capital Management Company, LP
13G/A
Amendment 1
|
0% |
5/23/2025
Event 5/21/2025
|
|
| AyurMaya Capital Management Company, LP | 0% | ||
| David E. Goel | 0% | ||
|
Madison Avenue Partners, LP
13D
|
5.1% |
4/30/2025
Event 4/29/2025
|
|
| Madison Avenue International LP | 5.1% | ||
| Madison Avenue Partners, LP | 5.1% | ||
| EMAI Management, LLC | 5.1% | ||
| Madison Avenue GP, LLC | 5.1% | ||
| Caraway Jackson Investments LLC | 5.1% | ||
| Eli Samaha | 5.1% | ||
| Trium Capital LLP 13D/A Amendment 1 |
4/29/2025
Event 3/6/2025
|
||
|
Tang Capital Management LLC
13D/A
Amendment 2
|
8.8% |
3/12/2025
Event 3/10/2025
|
|
| Tang Capital Management, LLC | 8.8% | ||
| Kevin Tang | 8.8% | ||
| Tang Capital Partners, LP | 5.0% | ||
| Tang Capital Partners International, LP | 3.8% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
| Concentra Biosciences, LLC | 0% | ||
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 3 | 4.6% |
3/7/2025
Event 2/28/2025
|
|
| Trium Capital LLP 13D | 5.4% |
3/6/2025
Event 3/6/2025
|
|
|
Tang Capital Management LLC
13D/A
Amendment 1
|
7.3% |
2/27/2025
Event 2/25/2025
|
|
| Tang Capital Management, LLC | 7.3% | ||
| Kevin Tang | 7.3% | ||
| Tang Capital Partners, LP | 4.1% | ||
| Tang Capital Partners International, LP | 3.2% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
| Concentra Biosciences, LLC | 0% | ||
|
Tang Capital Management LLC
13D
|
5.3% |
2/20/2025
Event 2/18/2025
|
|
| Tang Capital Management, LLC | 5.3% | ||
| Kevin Tang | 5.3% | ||
| Tang Capital Partners, LP | 3.0% | ||
| Tang Capital Partners International, LP | 2.3% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
| Concentra Biosciences, LLC | 0% | ||
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 | 12.8% |
2/14/2025
Event 12/31/2024
|
|
|
Citadel Advisors LLC
13G/A
Amendment 2
|
4.2% |
2/14/2025
Event 12/31/2024
|
|
| Citadel Advisors LLC | 4.2% | ||
| Citadel Advisors Holdings LP | 4.2% | ||
| Citadel GP LLC | 4.2% | ||
| Citadel Securities LLC | 0% | ||
| Citadel Securities Group LP | 0% | ||
| Citadel Securities GP LLC | 0% | ||
| Kenneth Griffin | 4.2% | ||
|
Integrated Core Strategies (US) LLC
13G/A
Amendment 1
|
4.7% |
2/10/2025
Event 12/31/2024
|
|
| Integrated Core Strategies (US) LLC | 4.7% | ||
| Millennium Management LLC | 4.7% | ||
| Millennium Group Management LLC | 4.7% | ||
| Israel A. Englander | 4.7% | ||
|
Access Industries Management, LLC
13D/A
Amendment 1
|
5.1% |
2/10/2025
Event 2/6/2025
|
|
| Access Industries Management, LLC | 5.1% | ||
| Access Industries Holdings LLC | 5.1% | ||
| AI Acel LLC | 5.1% | ||
| Len Blavatnik | 5.1% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q2 | 2 | 285 | $704.00 |
| 2025 Q1 | 111 | 73.9 M | $183 M |
| 2024 Q4 | 129 | 88.0 M | $276 M |
| 2024 Q3 | 127 | 88.1 M | $434 M |
| 2024 Q2 | 118 | 90.9 M | $401 M |
| 2024 Q1 | 128 | 94.8 M | $640 M |
| 2023 Q4 | 122 | 90.0 M | $671 M |
| 2023 Q3 | 121 | 83.8 M | $847 M |
| 2023 Q2 | 89 | 77.2 M | $1.60 B |